Just another sign that we are starting to see The Next Investing Boom emerge.
Establishing the infrastructure to support personalized medicine, creating a quick development pathway for therapies and improving the medical-device review process are among the major actions the Food and Drug Administration outlined in a new report released Wednesday designed to spur innovation.
The report was released on the same day the journal Health Affairs and the Center for the Study of the Presidency and Congress sponsored a briefing on Capitol Hill about personalized medicine, which tailors medical treatment to the individual characteristics of each patient. (source Modern Healthcare)
The tool that turned $10,000 into $2,800,000 in 2 years. HowToFindBigStocks.com
No comments:
Post a Comment